150 related articles for article (PubMed ID: 12627494)
1. Varicella-zoster virus isolates, but not the vaccine strain OKA, induce sensitivity to alpha-1 and beta-1 adrenergic stimulation of sensory neurones in culture.
Schmidt M; Kress M; Heinemann S; Fickenscher H
J Med Virol; 2003; 70 Suppl 1():S82-9. PubMed ID: 12627494
[TBL] [Abstract][Full Text] [Related]
2. Infection by human varicella-zoster virus confers norepinephrine sensitivity to sensory neurons from rat dorsal root ganglia.
Kress M; Fickenscher H
FASEB J; 2001 Apr; 15(6):1037-43. PubMed ID: 11292665
[TBL] [Abstract][Full Text] [Related]
3. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis of the Oka vaccine strain of varicella-zoster virus.
Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S45-8. PubMed ID: 18419407
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
7. Use of a rodent model to show that varicella-zoster virus ORF61 is dispensable for establishment of latency.
Sato H; Pesnicak L; Cohen JI
J Med Virol; 2003; 70 Suppl 1():S79-81. PubMed ID: 12627493
[TBL] [Abstract][Full Text] [Related]
8. Amplification and sequencing of varicella-zoster virus (VZV) gene 4: point mutation in a VZV strain causing chickenpox during pregnancy.
Chow VT; Lim KP
Acta Virol; 1997 Oct; 41(5):277-83. PubMed ID: 9607081
[TBL] [Abstract][Full Text] [Related]
9. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
Arvin AM
Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
[TBL] [Abstract][Full Text] [Related]
10. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
11. Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs.
Garry EM; Delaney A; Anderson HA; Sirinathsinghji EC; Clapp RH; Martin WJ; Kinchington PR; Krah DL; Abbadie C; Fleetwood-Walker SM
Pain; 2005 Nov; 118(1-2):97-111. PubMed ID: 16213091
[TBL] [Abstract][Full Text] [Related]
12. Molecular studies of Varicella zoster virus.
Quinlivan M; Breuer J
Rev Med Virol; 2006; 16(4):225-50. PubMed ID: 16791838
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella-zoster virus isolates.
Argaw T; Cohen JI; Klutch M; Lekstrom K; Yoshikawa T; Asano Y; Krause PR
J Infect Dis; 2000 Mar; 181(3):1153-7. PubMed ID: 10720545
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic understanding and control of varicella-zoster virus infection.
Asano Y
Vaccine; 2008 Nov; 26(50):6487-90. PubMed ID: 18694794
[TBL] [Abstract][Full Text] [Related]
15. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
16. Infection of human fetal dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine.
Somekh E; Levin MJ
J Med Virol; 1993 Jul; 40(3):241-3. PubMed ID: 8394874
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
Levin MJ; DeBiasi RL; Bostik V; Schmid DS
J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
[TBL] [Abstract][Full Text] [Related]
18. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
19. Pathogenetic tropism of varicella-zoster virus to primary human hepatocytes and attenuating tropism of Oka varicella vaccine strain to neonatal dermal fibroblasts.
Shiraki K; Yoshida Y; Asano Y; Yamanishi K; Takahashi M
J Infect Dis; 2003 Dec; 188(12):1875-7. PubMed ID: 14673767
[TBL] [Abstract][Full Text] [Related]
20. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]